Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation
Clinical trial NCT00865904 · COMPLETED
Trial details
- NCT number
- NCT00865904
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-12-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.